Michelle Maskaly

In this episode, Michelle and Christen speak with Marc O'Connor, chief operating officer at Curant Health, and Pharm Exec's Editor-in-Chief, Lisa Henderson with insights on the JPMorgan Healthcare Conference that took place at the beginning of January.

The biotech sector has managed to elude the negative perceptions saddling traditional pharma these days. We examine the reasons why.

Molly Harper, vice president of commercial development at Akcea Therapeutics, outlines best practices for this unique group of therapies

In this podcast, Pharmaceutical Executive editors, Christen Harm and Michelle Maskaly, discuss the 2018 pharma trends, specifically biosimilars and eEnablement, and takeaways from the 2017 Veeva European Commercial Summit.

Program puts a new-and very real-spin on patient nutrition.

Julia Cheek recently landed in the television history books when she accepted a $1 million offer on the TV show “Shark Tank," the largest valuation for a solo female entrepreneur in the show’s history.

Amid a widening net of health threats worldwide, alliances forged in research and response may be more critical than ever to stem the tide.

Figuring out the right formula to address global health-for the better.

With its convergence of healthcare talent and tech, the nation is turning into a prime destination for innovative startups.

Jennifer Miller talks about about pharma's reputation problem.

The internet giant’s latest service may also be another piece of the company’s pharma puzzle.

In this brief video, the photographer talks about how he set up the photo shoot to help showcase her leadership style.

Technology and other trends in medicine are driving the need for new strategies and investments in temperature sensitive packaging.

Former critical care nurse Cynthia Schwalm, now executive vice president and president of North American commercial operations for Ipsen, speaks with Pharm Exec about her formula for successful team building internally-and the importance today of stepping outside of the C-suite and into the world of the patient.

The agency’s new commissioner unveiled new digital health pilot programs to help navigate regulatory requirements.

Dogs and kids both spontaneously develop a number of cancers, making it a no-brainer for those on both sides of the disease to work together in finding new therapies.

The rapid development and take-up of digital technology is forever changing the way pharma engages with patients-but the industry’s ultimate potential in tapping digital health to transform patient care hinges on embracing new shifts in culture and business strategy.

An honoree at HBA’s recent Women of the Year awards luncheon, Bahija Jallal’s story is one of courage and resilience.

Pharma leaders go on the defensive over drug pricing regulations, while experts slam the politicization of healthcare.

New survey ranks the reputation of individual pharmaceutical companies.

Experts say knowing how to lead in uncertain times and being open to change is just as important as a degree.

Analysts who spoke with Pharm Exec expect the online retail giant to enter the pharma space within the next two years.

There will be 13 full-time positions dedicated to creating and providing guidance in the emerging subject area.

Among those honored at HBA’s Women of the Year awards luncheon, Bahija Jallal’s story is one of courage and resilience.

Past Lilly president and D.C. insider discusses some of the critical topics facing the U.S. healthcare industry.

How companies are closing the innovation gap between the lab and the patient, while also creating value for all stakeholders.

While technology is already impacting the pharma industry, automation and the Internet of things (IoT) will intensify over the next two years, and those companies that experiment and embrace it will have a “dramatic and competitive advantage.”